|
|
|
Volumn 18, Issue 103, 2009, Pages 205-
|
|
Fentanyl effervescent buccal tablets - For cancer patients with breakthrough pain: A second buccal formulation with minimal evaluation
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EFFENTORA;
FENTANYL;
MORPHINE;
PLACEBO;
UNCLASSIFIED DRUG;
APPLICATION SITE BURNING;
APPLICATION SITE PAIN;
APPLICATION SITE REACTION;
APPLICATION SITE ULCER;
CANCER PAIN;
CANCER PATIENT;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG RELEASE;
DRUG WITHDRAWAL;
EFFERVESCENT TABLET;
FIRST PASS EFFECT;
HUMAN;
MUCOSA INFLAMMATION;
SHORT SURVEY;
ADMINISTRATION, BUCCAL;
ANALGESICS, OPIOID;
BIOLOGICAL AVAILABILITY;
CHEMISTRY, PHARMACEUTICAL;
DOSAGE FORMS;
EUROPE;
FENTANYL;
HUMANS;
MOUTH MUCOSA;
NEOPLASMS;
PAIN, INTRACTABLE;
PALLIATIVE CARE;
PATIENT SATISFACTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TABLETS;
TREATMENT OUTCOME;
|
|
EID: 70350644880
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (3)
|
